Patent US4246262A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4246262A Expired / Lapsed US ⏱️ 0.0 years remaining

Derivatives of amidinopenicillanic acid

Assignee: Leo Pharma AS
•
Filing: 1978-06-08
•
Granted: 1981-01-20
•
Expires: 1998-06-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to new 6β-amidino-penicillanic acids of the formula: ##STR1## in which X is oxygen or sulphur, --A-- is aliphatic hydrocarbon, or a single bond, --B-- is aliphatic hydrocarbon, or a single bond; R 1 and R 2 stand for hydrogen, lower alkyl, phenyl or phenyl-lower alkyl; or R 2 is acyl or guanyl; or R 1 and R 2 together with the nitrogen atom can form a monocyclic, saturated ring or represent ##STR2## in which R 3 and R 4 each stands for hydrogen, lower alkyl, phenyl, or phenyl-lower alkyl, or R 3 and R 4 together with nitrogen form a monocyclic, saturated ring; --W-- stands for ##STR3## which represent saturated, monocyclic, bicyclic or spirocyclic ring systems, respectively; salts of the compounds of formula I, and easily hydrolyzable, esters thereof, and salts of such esters; the invention further relating to methods of producing the compounds; to intermediates in their preparation; to pharmaceutical compositions containing the compounds; and to dosage units thereof, and to their use. The compounds of the present invention are active against a variety of pathogenic microorganisms, including gram-positive and gram-negative bacteria.

Inventors

  • 👤 Ib S. Vangedal

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 01:31
CPC Classifications
C; C07; C07D; C07D223/00; C07D223/02; C07D223/06; C07D223/08; C07D223/10; A; A61; A61P; A61P31/00; A61P31/04; C07D211/00; C07D211/04; C07D211/06; C07D211/08; C07D211/18; C07D211/20; C07D211/36; C07D211/40; C07D211/44; C07D211/46; C07D499/00

Claims Analysis

Total Claims: 52
Claim 1
Independent Claim 316 words
A 6β-amidinopenicillanic acid of the general formula I: ##STR29## in which X stands for an oxygen or a sulphur atom, --A-- stands for a straight or branched, aliphatic hydrocarbon chain, containing from 2 to 4 carbon atoms, or --A-- can be a single bond, and --B-- stands for a straight or branched, saturated or unsaturated aliphatic hydrocarbon radical, containing from 1 to 4 carbon atoms, or --B-- can be a single bond; R 1 and R 2 stand for hydrogen, or a lower alkyl radical containing from 1 to 4 carbon atoms, a phenyl or phenyl-lower alkyl radical; and R 2 further stands for an acyl radical derived from a mono- or dibasic carboxylic acid, sulphuric acid, a sulphonic acid, a sulphinic acid, phosphoric acid, or a phosphoric acid, or R 2 can represent an unsubstituted or a lower alkyl or phenyl substituted radical selected from the group consisting of carbamoyl, guanyl and guanylcarbamoyl radicals; or R 1 and R 2 together with the nitrogen atom can form a monocyclic saturated ring having from 4 to 8 carbon atoms; and furthermore R 1 and R 2 together can represent a radical of the formula ##STR30## in which R 3 and R 4 each stands for hydrogen, lower alkyl, phenyl, or phenyl-lower alkyl radicals, or in which R 3 and R 4 together with the nitrogen atom form a monocyclic, saturated ring having from 4 to 8 carbon atoms; and in which the radical --W-- stands for the groupings: ##STR31## which represent saturated, monocyclic, bicyclic or spirocyclic ring systems, respectively, containing from 4 to 11 carbon atoms in total; and salts of the compounds of the formula I with pharmaceutically acceptable, non-toxic organic and inorganic and inorganic acids or bases, and easily hydrolyzable, pharmaceutically acceptable, non-toxic esters of the penicillanic acid derivatives of formula I and salts of such esters with pharmaceutically acceptable, non-toxic acids or bases.
Claim 2
Dependent Claim 316 words
A 6β-amidinopenicillanic acid of the general formula I: ##STR29## in which X stands for an oxygen or a sulphur atom, --A-- stands for a straight or branched, aliphatic hydrocarbon chain, containing from 2 to 4 carbon atoms, or --A-- can be a single bond, and --B-- stands for a straight or branched, saturated or unsaturated aliphatic hydrocarbon radical, containing from 1 to 4 carbon atoms, or --B-- can be a single bond; R 1 and R 2 stand for hydrogen, or a lower alkyl radical containing from 1 to 4 carbon atoms, a phenyl or phenyl-lower alkyl radical; and R 2 further stands for an acyl radical derived from a mono- or dibasic carboxylic acid, sulphuric acid, a sulphonic acid, a sulphinic acid, phosphoric acid, or a phosphoric acid, or R 2 can represent an unsubstituted or a lower alkyl or phenyl substituted radical selected from the group consisting of carbamoyl, guanyl and guanylcarbamoyl radicals; or R 1 and R 2 together with the nitrogen atom can form a monocyclic saturated ring having from 4 to 8 carbon atoms; and furthermore R 1 and R 2 together can represent a radical of the formula ##STR30## in which R 3 and R 4 each stands for hydrogen, lower alkyl, phenyl, or phenyl-lower alkyl radicals, or in which R 3 and R 4 together with the nitrogen atom form a monocyclic, saturated ring having from 4 to 8 carbon atoms; and in which the radical --W-- stands for the groupings: ##STR31## which represent saturated, monocyclic, bicyclic or spirocyclic ring systems, respectively, containing from 4 to 11 carbon atoms in total; and salts of the compounds of the formula I with pharmaceutically acceptable, non-toxic organic and inorganic and inorganic acids or bases, and easily hydrolyzable, pharmaceutically acceptable, non-toxic esters of the penicillanic acid derivatives of formula I and salts of such esters with pharmaceutically acceptable, non-toxic acids or bases.
Claim 3
Dependent Claim 12 words
A compound according to claim 1, in which --W-- stands for ##STR32##
Claim 4
Dependent Claim 12 words
A compound according to claim 1, in which --W-- stands for ##STR33##
Claim 5
Dependent Claim 12 words
A compound according to claim 1, in which --W-- stands for ##STR34##
Claim 6
Dependent Claim 12 words
A compound according to claim 1, in which X stands for oxygen.
Claim 7
Dependent Claim 12 words
A compound according to claim 1, in which X stands for sulphur.
Claim 8
Dependent Claim 14 words
A compound according to claim 1, in which --A-- stands for a single bond.
Claim 9
Dependent Claim 14 words
A compound according to claim 1, in which --B-- stands for a single bond.
Claim 10
Dependent Claim 27 words
A compound according to claim 1, in which --B-- stands for a straight or branched, saturated or unsaturated hydrocarbon radical containing from 1 to 4 carbon atoms.
Claim 11
Dependent Claim 75 words
A compound according to claim 2, in which R 1 and R 2 are selected from the group consisting of hydrogen and lower alkyl containing from 1 to 4 carbon atoms; A is a single bond or is a straight or branched carbon chain containing 2-4 carbon atoms, the ##STR35## represents a saturated monocyclic ring containing 4-8 carbon atoms, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable, non-toxic, pharmaceutically acceptable esters thereof and their salts.
Claim 12
Dependent Claim 25 words
A compound according to claim 10, in which --A-- is an ethylene, propylene, butylene, isopropylene, isobutylene or sec-butylene radical; or --A-- is a single bond.
Claim 13
Dependent Claim 35 words
A compound according to claim 9, in which --B-- is a methylene, ethylene, propylene, trimethylene, tetramethylene, propylidene, methyltrimethylene, vinylene, propenylene, butenylene, methylpropenylene, propynylene, butynylene, methylpropynylene radical, ethanylylidene or propanylylidene, or --B-- is a single bond.
Claim 14
Dependent Claim 16 words
A compound as in claim 10 wherein R 1 and R 2 are hydrogen or methyl.
Claim 15
Dependent Claim 15 words
A compound as in claim 10 wherein R 1 and R 2 are both hydrogen.
Claim 16
Dependent Claim 18 words
A compound as in claim 10 wherein A is a straight carbon atom chain containing 2-3 carbon atoms.
Claim 17
Dependent Claim 17 words
A compound as in claim 10 wherein A is a branched carbon chain containing 2-4 carbon atoms.
Claim 18
Dependent Claim 16 words
A compound as in claim 10 wherein the group ##STR36## contains 5 or 6 carbon atoms.
Claim 19
Dependent Claim 12 words
A compound as in claim 17 wherein the group ##STR37## is piperidyl-1.
Claim 20
Dependent Claim 12 words
A compound as in claim 17 wherein the group ##STR38## is hexahydro-1H-azepin-1-yl.
Claim 21
Dependent Claim 42 words
A compound according to claim 2 in which --A-- stands for a carbon chain containing from 2 to 3 carbon atoms, R 1 and R 2 stand for hydrogen, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof, and their salts.
Claim 22
Dependent Claim 17 words
6-[4'-(2"-aminoethylthiomethyl)-piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 23
Dependent Claim 17 words
6-[4'-(2"-aminoethylthiomethyl)-piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 24
Dependent Claim 17 words
6-[4'-(2"-aminoethoxy)-piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 25
Dependent Claim 17 words
6-[4'-(2"-aminoethoxy)-piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 26
Dependent Claim 17 words
6-[4'-(2"-diethylaminoethylthiomethyl)piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 27
Dependent Claim 17 words
6-[4'-(2"-diethylaminoethylthiomethyl)piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 28
Dependent Claim 17 words
6[4'-(1"-(2'"-diethylaminoethylthio)-ethyl)piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 29
Dependent Claim 17 words
6[4'-(1"-(2'"-diethylaminoethylthio)-ethyl)piperidino-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 30
Dependent Claim 17 words
6-[4'-(2"-aminoethoxy)-hexahydro-1H-azepin-1-yl-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 31
Dependent Claim 17 words
6-[4'-(2"-aminoethoxy)-hexahydro-1H-azepin-1-yl-methyleneamino]-penicillanic acid and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof and salts of said esters.
Claim 32
Dependent Claim 50 words
A compound according to claim 3 in which --A-- stands for a single bond or for a carbon chain containing from 2 to 4 carbon atoms, and in which R 1 and R 2 stand for hydrogen, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof, and their salts.
Claim 33
Dependent Claim 42 words
A compound according to claim 3 in which in thegrouping ##STR39## the individual rings have a maximum of 7 carbon atoms, --A-- contains from 2 to 4 carbon atoms, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof, and their salts.
Claim 34
Dependent Claim 38 words
A compound according to claim 27 in which the numbers of carbon atoms in the heterocyclic part of the ring is 4, and the total number of the carbon atoms in the ring system are 7 or 8.
Claim 35
Dependent Claim 50 words
A compound according to claim 4 in which --A-- stands for a single bond or for a carbon chain containing from 2 to 4 carbon atoms, and in which R 1 and R 2 stand for hydrogen, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof, and their salts.
Claim 36
Dependent Claim 44 words
A compound according to claim 4 in which, in the spirocyclic grouping ##STR40## the individual rings have a maximum of 7 carbon atoms, --A-- contains from 2 to 4 carbon atoms, and pharmaceutically acceptable, non-toxic salts and easily hydrolyzable esters thereof, and their salts.
Claim 37
Dependent Claim 48 words
A salt of a compound of formula I of claim 1, which is a zwitterion or a mono- or dibasic salt, formed with hydrochloric acid, phosphoric acid, nitric acid, p-toluenesulphonic acid, acetic acid, propionic acid, citric acid, tartaric acid, or maleic acid or another antibiotic with acidic character.
Claim 38
Dependent Claim 36 words
A salt of a compound of formula I of claim 1, which is a salt with an alkali metal an alkaline earth metal, with ammonia or triethylamine, hydroxylower alkylamines, cycloalkylamines, or another antibiotic with basic character.
Claim 39
Dependent Claim 39 words
A salt as claimed in claim 32 wherein the hydroxy-lower alkylamines are selected from the group consisting of 2-hydroxyethylamine, bis-(2-hydroxyethyl)-amine or tris-(2-hydroxyethyl)-amine, the cycloalkylamine is dicyclohexylamine and the benzylamines are selected from the group consisting, of N,N'-dibenzyl-ethylenediamine, and dibenzylamine.
Claim 40
Dependent Claim 45 words
An easily hydrolyzable, pharmaceutically acceptable, non-toxic ester of a compound of formula I of claim 1, which ester is selected from the group consisting of alkanoyloxyalkyl esters, alkoxycarbonyloxyalkyl esters, lactonyl esters, lower alkoxymethyl and acylaminomethyl esters; the benzyl ester, the cyanomethyl ester, and 1-carbalkoxy-2-oxopropyl esters.
Claim 41
Dependent Claim 45 words
An antibacterial composition in dosage unit form for enteral or parenteral treatment of patients which comprises as an active ingredient 0.01 g to 3 g of a compound as claimed in claim 1 calculated as the free acid together with an non-toxic pharmaceutically acceptable carrier.
Claim 42
Dependent Claim 34 words
An antibacterial composition in dosage unit form as claimed in claim 35 for oral treatment of patients, and containing from 0.05 g to 1.5 g of the active ingredient, calculated as the free acid.
Claim 43
Dependent Claim 39 words
An antibacterial composition in dosage unit form as claimed in claim 36 and containing as the active component the compound 6-[4'-(2"-aminoethylthiomethyl)-piperidino-methyleneamino]-penicillanic acid, or a pharmaceutically acceptable, non-toxic salt or easily hydrolyzable ester thereof, or a salt of said ester.
Claim 44
Dependent Claim 20 words
An antibacterial composition in dosage unit form as claimed in claim 37 in the form of tablets, pills or capsules.
Claim 45
Dependent Claim 46 words
An antibacterial composition in dosage unit form for parenteral treatment of patients, and containing from 0.1 g to 1 g of a compound as claimed in claim 1, calculated as the free acid, as such or in the form of one of its now toxic salts.
Claim 46
Dependent Claim 36 words
An antibacterial composition containing as the active component a compound as claimed in claim 1 together with carrier substances and auxilliary agents, containing from 1% to 95% of the active component, calculated as the free acid.
Claim 47
Dependent Claim 46 words
An antibacterial composition as claimed in claim 40 containing the active component together with an active additive selected from the group consisting of known penicillins, cephalosporins, amidinopenicillanic acid derivatives, aminoglycoside antibiotics, trimethoprim or clavulanic acid, the ratio between the active compounds being between 1:20 and 20:1.
Claim 48
Dependent Claim 38 words
An antibacterial composition as claimed in claim 41 in dosage unit form for enteral and parenteral treatment of patients and containing from 0.01 g to 3 g in total of the active components, as present, in the composition.
Claim 49
Dependent Claim 20 words
The pharmaceutical composition as claimed in claim 41 wherein the ratio between the active compounds is between 1:5 and 5:1.
Claim 50
Dependent Claim 86 words
A compound according to claim 1 wherein the easily hydrolyzable, pharmaceutically acceptable, non-toxic esters of the penicillanic acid derivatives of formula I are diesters of the formula II: ##STR41## in which Y and Z can be the same or different and stand for an acyl radical of a compound of formula I, and Z furthermore can be the acyl radical of other known β-lactam derivatives, R 5 stands for hydrogen, methyl, ethyl, or phenyl, and salts of such esters with pharmaceutically acceptable, non-toxic acids or bases.
Claim 51
Dependent Claim 29 words
An ester as claimed in claim 44 wherein the β-lactam derivative is selected from the group consisting of penicillins, caphalosporins, amidinopenicillanic acids, amidino-Δ 3 -cephemcarboxylic acids and calvulanic acid.
Claim 52
Dependent Claim 56 words
A method of treating patients suffering from bacterial infections, which comprises administering to said patients a compound as claimed in claim 1, alone or in combination with another active ingredient in daily doses from 0.2 to 30 g of said compounds and said active ingredient, the weight of said compound being calculated as the free acid.

References Cited (Backward Citations)

US3957764A Cited
GB1303491A Cited
US3755588A Cited
GB1315566A Cited
GB1405886A Cited
GB1427139A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-01-20 1984-07-21 1985-01-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-01-20 1988-07-21 1989-01-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-01-20 1992-07-21 1993-01-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag